Literature DB >> 6402715

Progressive change in cerebral blood flow during the first three weeks after subarachnoid hemorrhage.

C H Meyer, D Lowe, M Meyer, P L Richardson, G Neil-Dwyer.   

Abstract

Cerebral blood flow (CBF) was estimated from each cerebral hemisphere by the 133Xe inhalation method. Daily estimates were made during the first 3 weeks after subarachnoid hemorrhage (1265 studies in 116 patients). Some of the patients were taking adrenergic blocking drugs (propranolol and phentolamine), others were taking tranexamic acid, and the rest were taking no drugs. CBF was also studied in 67 normal subjects. The resting CBF was related inversely to age not only for normal subjects but also for patients after subarachnoid hemorrhage (SAH). The CBF fell progressively during the first 2 weeks after SAH and was abnormally low throughout the 3 weeks after hemorrhage. For any 1 day after SAH, those patients who were fully alert had the smallest reduction in CBF. The progressive changes in CBF occurred whether or not an aneurysm was present on angiograms. For aneurysms situated to one side of the midline, the changes in CBF affected both sides of the brain. The progressive decline in CBF was least in those patients who subsequently made the best clinical recovery. Arterial pCO2 seemed to influence CBF throughout the 3 weeks after SAH. During the 2nd week, CBF was especially low in SAH patients treated with tranexamic acid. The serial changes in CBF are discussed in relation to current views concerning the timing of operation for ruptured aneurysms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6402715     DOI: 10.1227/00006123-198301000-00010

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  20 in total

Review 1.  CT perfusion cerebral blood flow imaging in neurological critical care.

Authors:  Mark R Harrigan; Jody Leonardo; Kevin J Gibbons; Lee R Guterman; L Nelson Hopkins
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Self-retaining brain retractor pressure during intracranial procedures.

Authors:  J Rosenørn
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

3.  The influence of intermittent versus continuous brain retractor pressure on regional cerebral blood flow and neuropathology in the rat.

Authors:  J Rosenørn; N H Diemer
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

Review 4.  Antifibrinolytic agents in subarachnoid haemorrhage.

Authors:  K W Lindsay
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

5.  Beta-blockade benefits patients following a subarachnoid haemorrhage.

Authors:  G Neil-Dwyer; P Walter; J M Cruickshank
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Cortical blood flow recorded during early or delayed surgery for ruptured intracranial aneurysms.

Authors:  G L Viale; M Cossu; F Cella; M Balestrero; A Rossi; D Masoni
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Delayed cerebral ischaemia: the pathological substrate.

Authors:  G Neil-Dwyer; D A Lang; B Doshi; C J Gerber; P W Smith
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

8.  "Head-shaking syndrome" neurological deterioration during continuous head-shaking as an adjunct to cisternal irrigation for clot removal in patients with acute subarachnoid haemorrhage.

Authors:  N Aoki
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

9.  Clinical significance of the finding of subarachnoid blood on CT scan after head injury.

Authors:  A Kakarieka; R Braakman; E H Schakel
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  Brain energy metabolism in the acute stage of experimental subarachnoid haemorrhage: local changes in cerebral glucose utilization.

Authors:  D d'Avella; R Cicciarello; M Zuccarello; F Albiero; A Romano; F F Angileri; F M Salpietro; F Tomasello
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.